PIK3CA Mutation Detection with Blocking Probes and Melting Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting PIK3CA mutations in clinical tumor samples are limited by low sensitivity and high false negatives, impacting clinical diagnosis and patient management due to the low amounts of mutations present.
Innovation Solution
A method combining allele-specific PCR, competitive blocking probes, and melting analysis is used to enhance the detection of PIK3CA hotspot mutations in CTCs, cfDNA, and FFPE tissues, achieving sensitivity of 0.05% and specificity of 100% by enriching rare alleles and minimizing wild-type amplification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional PCR methods are used to detect PIK3CA mutations, then the detection process is simple, but the sensitivity is low leading to high false negatives
Solution Approach 1:
The detection method is divided into multiple distinct stages: asymmetric PCR amplification to enrich mutant alleles, competitive blocking probe addition to suppress wild-type amplification, and melting curve analysis for detection. This segmentation allows each stage to optimize for its specific function, achieving high sensitivity while maintaining procedural clarity.
Solution Approach 2:
The asymmetric PCR amplification is performed beforehand to preferentially amplify mutant alleles before the actual detection step. This preliminary enrichment of rare mutant DNA sequences ensures that when detection occurs, the mutant alleles are already concentrated above the detection threshold, solving the sensitivity problem.
2Measurement precision
If allele-specific PCR with blocking probes is used, then detection sensitivity reaches 0.05%, but the procedure becomes more complex
Solution Approach 1:
The method merges asymmetric PCR amplification, competitive blocking, and melting curve detection into a single unified assay protocol. By combining these functions into one integrated procedure using standard reagents and equipment, the complexity increase is minimized while achieving 0.05% detection sensitivity.
Solution Approach 2:
The blocking probes are designed to automatically suppress wild-type amplification during the PCR process without requiring separate intervention steps. The system self-regulates by using the blocking probes to prevent false positive amplification of wild-type sequences, simplifying the operational workflow despite the enhanced sensitivity.
3Quantity of substance
If standard cfDNA extraction kits are used, then extraction is straightforward, but efficiency and yield are low
Solution Approach 1:
The extraction protocol optimizes critical parameters including incubation time, temperature, and reagent ratios to maximize cfDNA recovery. By adjusting these parameters within the standard kit framework, the method achieves higher yield and efficiency without requiring completely different extraction technology or equipment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively detects PIK3CA mutations at very low concentrations, improving diagnostic accuracy and clinical utility for predicting treatment response and recurrence in various cancers, particularly breast cancer.
Implementation Method 1
performing an asymmetric and allele specific Polymerase Chain Reaction (PCR)
Implementation Method 2
performing a melting analysis of the DNA produced in the PCR
Implementation Method 3
an unlabeled blocking probe that is an oligonucleotide complementary to the wild type sequence
Data Source
AI summary
An ultra-sensitive, specific methodology for detecting PIK3CA mutations in biological samples of cancer patients, comprises a combination of allele-specific, asymmetric rapid PCR and melting analysis in a DNA sample from Circulating Tumor Cells, cell-free DNA in plasma/serum, or Formalin-Fixed Paraffin-Embedded tissues. Using the allele-specific primers for hotspot mutations in exons 9 and 20 (E545K and H1047R), detection can enhance amplification of mutant PIK3CA allele sequence, whereas presence of corresponding competitive blocking unlabeled probes for each exon can avoid non-specific amplification of wild-type PIK3CA sequence increasing the sensitivity and the specificity of method. The mutational detection is completed with melting curve analysis of the unlabeled probe and DNA template of the mutant PIK3CA sequence. Evaluation of PIK3CA mutational status on CTC in peripheral blood and cfDNA in plasma/serum of patients has potential for clinical applications and therapeutic interventions, since presence of PIK3CA mutations is associated with response to molecular targeted therapies.